Premium Industrial News

Catalent to Spend $100 Million on Italian Drugs Plant

Catalent to Spend $100 Million on Italian Drugs Plant

pharmaceutical

Industry Segment: Pharmaceutical & Biotech | Word Count: 651 Words

GALWAY, IRELAND--August 16, 2021--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Catalent (NYSE: CTLT) (Somerset, New Jersey), a leading contract development and manufacturing organization (CDMO), has kicked off a $100 planned expansion of its Italian facility in Anagni.

Within this article: Details project investment, timelines, existing COVID-19 vaccine fill & finish contracts

This Premium Article can be purchased individually or as part of a subscription

Subscribe Now!(All Fields Required)

Subscription Type:

  • Pay-Per-Article - $5.95
  • Annual Premium News Subscription - $365.00
Pricing Help?